{"id":"lng","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Nausea"},{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"20-30","effect":"Irregular bleeding"}]},"_chembl":null,"_dailymed":{"setId":"bc3f76ef-66dd-c8eb-e053-2995a90a59f1","title":"D08 LNG-DRN (ACONITUM NAPELLUS, AMERICAN GINSENG, ARSENICUM IODATUM, BLATTA ORIENTALIS, CALCAREA SULPHURICA, CARPINUS BETULUS FLOWER, CUPRUM METALLICUM, GRINDELIA, HEPAR SULPHURIS CALCAREUM, IPECACUANHA, JUSTICIA ADHATODA, KALI IODATUM, LOBELIA INFLATA, NAPHTHALINUM, NARCISSUS PSEUDONARCISSUS, PINE TAR, POPULUS CANDICANS, TABACUM, THUJA OCCIDENTALIS, THYMUS SERPYLLUM) SOLUTION/ DROPS [APEX ENERGETICS INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levonorgestrel works primarily by inhibiting the LH surge necessary for ovulation. It also increases cervical mucus viscosity to impede sperm transport and alters the endometrium to reduce implantation likelihood. As a marketed contraceptive, it is available in multiple formulations including oral pills, emergency contraception, and intrauterine devices.","oneSentence":"LNG (levonorgestrel) is a synthetic progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:43:17.225Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Oral contraception"},{"name":"Emergency contraception (Plan B)"},{"name":"Intrauterine contraceptive device"}]},"trialDetails":[{"nctId":"NCT07349641","phase":"PHASE2","title":"A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-06","conditions":"Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma","enrollment":55},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT07107334","phase":"PHASE2","title":"A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia","status":"RECRUITING","sponsor":"University of Florida","startDate":"2026-03","conditions":"Endometrioid Endometrial Adenocarcinoma","enrollment":20},{"nctId":"NCT05172999","phase":"PHASE2, PHASE3","title":"Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2022-01-08","conditions":"Atypical Endometrial Hyperplasia, Obesity, Fertility Issues","enrollment":30},{"nctId":"NCT07449299","phase":"PHASE3","title":"Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel","status":"NOT_YET_RECRUITING","sponsor":"University of Utah","startDate":"2027-03","conditions":"Emergency Contraception, Contraception, COX-2 Inhibitor","enrollment":1458},{"nctId":"NCT07074327","phase":"PHASE1","title":"Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2025-07-11","conditions":"Autosomal Dominant Polycystic Kidney Disease (ADPKD)","enrollment":74},{"nctId":"NCT06942936","phase":"PHASE1","title":"A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-28","conditions":"Healthy Participants","enrollment":51},{"nctId":"NCT05903131","phase":"PHASE2","title":"Uterine Preservation Via Lifestyle Transformation","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-10-24","conditions":"Endometrial Hyperplasia, Grade 1 Endometrial Cancer","enrollment":96},{"nctId":"NCT06552598","phase":"PHASE1","title":"The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2024-04-01","conditions":"Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer","enrollment":97},{"nctId":"NCT07010146","phase":"PHASE2","title":"Role of Estrogen on Skeletal Outcomes in FHA","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-07-01","conditions":"Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)","enrollment":150},{"nctId":"NCT05829460","phase":"PHASE2","title":"Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia","status":"WITHDRAWN","sponsor":"Washington University School of Medicine","startDate":"2025-03-12","conditions":"Endometrial Hyperplasia","enrollment":""},{"nctId":"NCT01166412","phase":"PHASE1, PHASE2","title":"A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)","status":"COMPLETED","sponsor":"Premier Research","startDate":"2010-12","conditions":"Contraception","enrollment":121},{"nctId":"NCT05916469","phase":"","title":"Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2025-09-24","conditions":"Heavy Menstrual Bleeding, Bleeding Disorder, Von Willebrand Diseases","enrollment":300},{"nctId":"NCT07272889","phase":"PHASE1","title":"Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)","status":"NOT_YET_RECRUITING","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-12","conditions":"Healthy Volunteer Study","enrollment":24},{"nctId":"NCT07248553","phase":"","title":"Timing of LNG-IUD Insertion and Ovarian Cyst Formation","status":"RECRUITING","sponsor":"Gaziosmanpasa Research and Education Hospital","startDate":"2025-06-01","conditions":"Ovarian Cysts, Menstrual Cycle, Intrauterine Device (IUD)","enrollment":60},{"nctId":"NCT03537768","phase":"PHASE4","title":"Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg","status":"TERMINATED","sponsor":"Kimberly Myer","startDate":"2018-07-12","conditions":"Contraception","enrollment":532},{"nctId":"NCT03455075","phase":"PHASE2","title":"Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men","status":"COMPLETED","sponsor":"Premier Research","startDate":"2018-04-16","conditions":"Healthy, Men, Male Contraception","enrollment":92},{"nctId":"NCT06354257","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-04-05","conditions":"Tuberculosis","enrollment":20},{"nctId":"NCT06186271","phase":"","title":"International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)","status":"RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2025-04-24","conditions":"Contraception","enrollment":68100},{"nctId":"NCT06028555","phase":"","title":"International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study","status":"RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2023-06-28","conditions":"Contraception, Birth Control","enrollment":101000},{"nctId":"NCT06071442","phase":"PHASE1","title":"Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2024-01-17","conditions":"Healthy Participants","enrollment":60},{"nctId":"NCT05316493","phase":"PHASE2, PHASE3","title":"Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia","status":"RECRUITING","sponsor":"Xiaojun Chen","startDate":"2022-06-13","conditions":"Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity","enrollment":172},{"nctId":"NCT07077876","phase":"","title":"Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-06-20","conditions":"Endometrial Adenocarcinoma, Endometrial Hyperplasia, Fertility Preservation","enrollment":100},{"nctId":"NCT01088178","phase":"NA","title":"Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2009-11","conditions":"Contraception","enrollment":""},{"nctId":"NCT01161095","phase":"NA","title":"A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2010-07-01","conditions":"Contraception, Postpartum Period","enrollment":""},{"nctId":"NCT06671405","phase":"PHASE1","title":"An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-09-25","conditions":"Dyslipidaemia","enrollment":59},{"nctId":"NCT06162611","phase":"PHASE4","title":"Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo","status":"RECRUITING","sponsor":"Lori Gawron","startDate":"2023-11-06","conditions":"Emergency Contraception","enrollment":790},{"nctId":"NCT05233956","phase":"NA","title":"Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya","status":"RECRUITING","sponsor":"FHI 360","startDate":"2023-10-23","conditions":"Anemia","enrollment":600},{"nctId":"NCT05896384","phase":"PHASE1","title":"A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-12-21","conditions":"Healthy","enrollment":32},{"nctId":"NCT06793943","phase":"PHASE1","title":"A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2025-01-23","conditions":"Healthy Volunteers","enrollment":78},{"nctId":"NCT04948489","phase":"PHASE2","title":"IUD and Norethindrone Acetate for Treatment of Endometriosis","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2026-01-01","conditions":"Endometriosis","enrollment":""},{"nctId":"NCT06657105","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-11-01","conditions":"Healthy Participants","enrollment":22},{"nctId":"NCT06783192","phase":"PHASE1","title":"A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-08-14","conditions":"Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis","enrollment":14},{"nctId":"NCT06727734","phase":"PHASE3","title":"Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-12","conditions":"Contraception","enrollment":980},{"nctId":"NCT02076217","phase":"","title":"Quick Start of Highly Effective Contraception","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2014-02","conditions":"IUD, Contraceptive Implant, Contraception","enrollment":1030},{"nctId":"NCT05041699","phase":"PHASE1, PHASE2","title":"PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2022-06-20","conditions":"Pharmacokinetics, Safety Issues, Bleeding","enrollment":40},{"nctId":"NCT03660046","phase":"","title":"Contraceptive Hormones, Immunity, and Microbiome Evaluation","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-12-07","conditions":"Hormonal Contraception","enrollment":155},{"nctId":"NCT06620939","phase":"NA","title":"The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence","status":"NOT_YET_RECRUITING","sponsor":"Zhang Jian","startDate":"2024-12-01","conditions":"Endometrial Polyp","enrollment":558},{"nctId":"NCT03241888","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Atypical Endometrial Hyperplasia","enrollment":180},{"nctId":"NCT06577168","phase":"","title":"Menstrual Pattern Within Six Months of Levonogestrel IUS Insertion","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-12-01","conditions":"Contraception","enrollment":300},{"nctId":"NCT06468215","phase":"NA","title":"Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-07","conditions":"Carcinoma, Endometrioid, Fertility Preservation","enrollment":16},{"nctId":"NCT06380205","phase":"PHASE1","title":"A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2024-05-07","conditions":"Healthy Participants","enrollment":24},{"nctId":"NCT02616146","phase":"PHASE3","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2015-12-01","conditions":"Contraception","enrollment":2016},{"nctId":"NCT05444582","phase":"PHASE4","title":"Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-11-07","conditions":"Contraception","enrollment":1404},{"nctId":"NCT02828904","phase":"","title":"RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2022-03-10","conditions":"Venous Thromboembolism","enrollment":124000},{"nctId":"NCT04778514","phase":"NA","title":"A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention","status":"COMPLETED","sponsor":"Population Council","startDate":"2022-12-07","conditions":"HIV Infections, Contraception","enrollment":30},{"nctId":"NCT01721798","phase":"NA","title":"Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women","status":"COMPLETED","sponsor":"FHI 360","startDate":"2013-11-10","conditions":"HIV","enrollment":199},{"nctId":"NCT00131885","phase":"PHASE4","title":"Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel","status":"COMPLETED","sponsor":"University of Utah","startDate":"2005-08","conditions":"Contraception","enrollment":36},{"nctId":"NCT03493295","phase":"","title":"Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-04-25","conditions":"Contraception","enrollment":587},{"nctId":"NCT05613777","phase":"PHASE1","title":"A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2022-11-24","conditions":"Healthy","enrollment":19},{"nctId":"NCT04814927","phase":"PHASE4","title":"Impact of Contraceptives on Cervico-Vaginal Mucosa","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2021-03-01","conditions":"Mucosal Inflammation, Contraceptive; Complications, Intrauterine","enrollment":112},{"nctId":"NCT05986344","phase":"","title":"Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-30","conditions":"Intrauterine Contraceptive Device Complication","enrollment":165},{"nctId":"NCT04910711","phase":"PHASE4","title":"Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV","status":"UNKNOWN","sponsor":"Botswana Harvard AIDS Institute Partnership","startDate":"2021-10-21","conditions":"Human Immunodeficiency Virus, Contraception, ART","enrollment":140},{"nctId":"NCT04897217","phase":"PHASE3","title":"Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-06-30","conditions":"Endometrial Hyperplasia","enrollment":""},{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT04785950","phase":"","title":"The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-02-21","conditions":"Hormonal Intrauterine Contraception","enrollment":316},{"nctId":"NCT02863445","phase":"PHASE4","title":"Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2017-07-06","conditions":"Obesity","enrollment":70},{"nctId":"NCT05770297","phase":"NA","title":"Effect of Propolis Administration for Dysmenorrhea in Endometriosis Patient With Levonorgestrel Implant Therapy","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2022-07-12","conditions":"Endometriosis, Dysmenorrhea","enrollment":24},{"nctId":"NCT00635362","phase":"NA","title":"Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-05","conditions":"Healthy","enrollment":42},{"nctId":"NCT00653159","phase":"PHASE4","title":"Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-07","conditions":"Contraception","enrollment":23},{"nctId":"NCT05505162","phase":"PHASE1","title":"Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-08-24","conditions":"Healthy Female Participants","enrollment":24},{"nctId":"NCT04385667","phase":"PHASE2, PHASE3","title":"LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2020-05-20","conditions":"Atypical Endometrial Hyperplasia","enrollment":143},{"nctId":"NCT05565573","phase":"PHASE2, PHASE3","title":"Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients","status":"UNKNOWN","sponsor":"Hua Li","startDate":"2022-11-01","conditions":"Fertility Sparing","enrollment":148},{"nctId":"NCT00877344","phase":"PHASE4","title":"Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2009-06","conditions":"Pregnancy","enrollment":474},{"nctId":"NCT02985541","phase":"PHASE3","title":"Mirena Extension Trial","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-12-22","conditions":"Contraception","enrollment":364},{"nctId":"NCT05343546","phase":"NA","title":"Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2022-06","conditions":"Incomplete Abortion, Intrauterine Contraception, Misoprostol","enrollment":2076},{"nctId":"NCT02662634","phase":"PHASE2","title":"A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"GU Research Network, LLC","startDate":"2016-03","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":""},{"nctId":"NCT03153709","phase":"","title":"Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-08-17","conditions":"HIV Infections","enrollment":1382},{"nctId":"NCT00511355","phase":"PHASE3","title":"Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Contraception","enrollment":121},{"nctId":"NCT00511342","phase":"PHASE3","title":"Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Contraception","enrollment":110},{"nctId":"NCT01044056","phase":"PHASE4","title":"A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-03","conditions":"Contraception","enrollment":24},{"nctId":"NCT01873170","phase":"","title":"Quantification of Immune Cells in Women Using Contraception (CHIC II)","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-08","conditions":"HIV, Immune Cells (Mucosal and Systemic), Contraception","enrollment":326},{"nctId":"NCT03819114","phase":"PHASE2","title":"Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2019-05-06","conditions":"HIV Infections, Tuberculosis","enrollment":122},{"nctId":"NCT05152667","phase":"","title":"Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin","status":"UNKNOWN","sponsor":"Wael Elbanna Clinic","startDate":"2021-11-27","conditions":"Adenomyosis, IVF","enrollment":354},{"nctId":"NCT03317795","phase":"PHASE4","title":"Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids","status":"COMPLETED","sponsor":"Shannon K. Laughlin-Tommaso","startDate":"2017-11-14","conditions":"Heavy Menstrual Bleeding, Menorrhagia, Uterine Fibroids","enrollment":18},{"nctId":"NCT04319796","phase":"","title":"European Registry on Rare Neurological Diseases","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2021-10","conditions":"Rare Diseases","enrollment":5000},{"nctId":"NCT03463252","phase":"PHASE2, PHASE3","title":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","status":"RECRUITING","sponsor":"West China Second University Hospital","startDate":"2018-04-01","conditions":"Endometrial Cancer, Atypical Endometrial Hyperplasia","enrollment":224},{"nctId":"NCT01650168","phase":"","title":"Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2012-07","conditions":"Contraception","enrollment":101498},{"nctId":"NCT04339348","phase":"PHASE3","title":"Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-04-30","conditions":"Contraception","enrollment":210},{"nctId":"NCT02267616","phase":"NA","title":"Effectiveness of Prolonged Use of IUD/Implant for Contraception","status":"COMPLETED","sponsor":"Indiana University","startDate":"2011-12","conditions":"Contraception","enrollment":1076},{"nctId":"NCT02403401","phase":"PHASE3","title":"Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-05-15","conditions":"Contraception","enrollment":1471},{"nctId":"NCT03182140","phase":"","title":"KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-06","conditions":"Contraception","enrollment":1134},{"nctId":"NCT02556411","phase":"NA","title":"Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)","status":"UNKNOWN","sponsor":"University of Cagliari","startDate":"2021-06-01","conditions":"Adenomyosis, Chronic Pelvic Pain","enrollment":50},{"nctId":"NCT03428854","phase":"","title":"Adenomyosis: Genomic Mechanisms and Biological Response","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-12-01","conditions":"Adenomyosis, Abnormal Uterine Bleeding","enrollment":""},{"nctId":"NCT02038335","phase":"","title":"HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2014-02","conditions":"Contraception, HIV, Immune Cells (Mucosal and Systemic)","enrollment":451},{"nctId":"NCT03992937","phase":"NA","title":"Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2019-06-20","conditions":"Endometrial Hyperplasia Without Atypia","enrollment":132},{"nctId":"NCT03241914","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Endometrial Neoplasm Malignant Stage I","enrollment":64},{"nctId":"NCT02357368","phase":"PHASE4","title":"Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk","status":"COMPLETED","sponsor":"Lisa Haddad","startDate":"2015-02","conditions":"HIV, Contraception","enrollment":59},{"nctId":"NCT02577913","phase":"","title":"European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception","status":"TERMINATED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2015-11","conditions":"Contraception","enrollment":2281},{"nctId":"NCT04474548","phase":"NA","title":"Postplacental LNG-IUD Ultrasound Use Study","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2020-10-05","conditions":"IUD Insertion Complication","enrollment":254},{"nctId":"NCT03368898","phase":"","title":"Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding","status":"COMPLETED","sponsor":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","startDate":"2017-01-01","conditions":"Heavy Menstrual Bleeding","enrollment":104},{"nctId":"NCT03984825","phase":"PHASE1","title":"Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2019-06-13","conditions":"HIV Infections","enrollment":23},{"nctId":"NCT01805817","phase":"PHASE4","title":"Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality","status":"WITHDRAWN","sponsor":"Istanbul Training and Research Hospital","startDate":"2012-12","conditions":"Contraceptive Methods Comparison","enrollment":""},{"nctId":"NCT04309643","phase":"PHASE1","title":"Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects","status":"COMPLETED","sponsor":"Concert Pharmaceuticals","startDate":"2020-06-09","conditions":"Healthy Volunteers","enrollment":21},{"nctId":"NCT02158572","phase":"PHASE3","title":"Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System","status":"COMPLETED","sponsor":"Agile Therapeutics","startDate":"2014-08","conditions":"Healthy","enrollment":2032},{"nctId":"NCT04355598","phase":"PHASE4","title":"Cervical Lidocaine-Prilocaine Cream vs Glyceryl Trinitrate Cream in Nulliparous Women With LNG-IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-04-30","conditions":"Contraception","enrollment":195},{"nctId":"NCT04312061","phase":"PHASE3","title":"Effect of Oral Tramadol Administration Prior to IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-30","conditions":"Contraception","enrollment":108},{"nctId":"NCT04311658","phase":"PHASE3","title":"Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-30","conditions":"Contraception","enrollment":88},{"nctId":"NCT04301349","phase":"PHASE3","title":"Dinoprostone vs Misoprostol Before LNG-IUD Insertion","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"IUD Insertion Pain","enrollment":200},{"nctId":"NCT02341027","phase":"NA","title":"Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-01","conditions":"Contraceptive Implant Utilization, Lactation","enrollment":205}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2722,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Levonorgestrel implant"],"phase":"marketed","status":"active","brandName":"LNG","genericName":"LNG","companyName":"FHI 360","companyId":"fhi-360","modality":"Small molecule","firstApprovalDate":"","aiSummary":"LNG (levonorgestrel) is a synthetic progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions. Used for Oral contraception, Emergency contraception (Plan B), Intrauterine contraceptive device.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}